SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-06-053647
Filing Date
2006-08-10
Accepted
2006-08-10 16:51:19
Documents
3
Period of Report
2006-08-07
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES a06-17813_18k.htm 8-K 24669
2 EX-99.1 a06-17813_1ex99d1.htm EX-99.1 8471
3 GRAPHIC g178131mmi001.jpg GRAPHIC 2778
  Complete submission text file 0001104659-06-053647.txt   38836
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114 2062817001
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16614 | Film No.: 061021911
SIC: 2835 In Vitro & In Vivo Diagnostic Substances